Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Mice with autoimmune hair loss showed signs of heart problems.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Skin treatment can lower life quality for patients with skin conditions.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Monkeys with more anxious or inhibited temperaments tend to have less hair loss.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Ruxolitinib treatment may cause eyelash growth.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Collecting hair for cortisol analysis is possible in low-income mother-toddler pairs.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

Albendazole may cause hair loss.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Finasteride's two formulations absorb similarly, showing bioequivalence.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.